Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 8/20 | 0.46 |
| ▸ | CALCR | P30988 | 8/20 | 0.46 |
| ▸ | APLNR | P35414 | 1/20 | 0.45 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | KDM5A | P29375 | 1/20 | 0.44 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.44 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.40 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12337799 | 0.91 | RAMP3 (0.46) | RAMP3CALCRAPLNRIL23RKDM1A | |
| SCHEMBL16340730 | 0.91 | RAMP3 (0.50) | RAMP3CALCRAPLNRIL23RKDM1A | |
| SCHEMBL16351203 | 0.84 | RAMP3 (0.48) | RAMP3CALCRAPLNRIL23RNMUR2 | |
| SCHEMBL12339085 | 0.78 | RAMP3 (0.46) | RAMP3CALCRIL23R | |
| SCHEMBL16351204 | 0.78 | RAMP3 (0.46) | RAMP3CALCRIL23R | |
| SCHEMBL12314880 | 0.77 | RAMP3 (0.47) | RAMP3CALCRIL23R | |
| SCHEMBL12314876 | 0.77 | RAMP3 (0.47) | RAMP3CALCRIL23R | |
| SCHEMBL13084700 | 0.77 | RAMP3 (0.47) | RAMP3CALCRIL23R | |
| SCHEMBL13084645 | 0.77 | RAMP3 (0.47) | RAMP3CALCRIL23R | |
| SCHEMBL16340628 | 0.76 | APLNR (0.42) | RAMP3CALCRAPLNRIL23RNMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263739-B2 | also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis | BRACCO SUISSE SA (CH) | 2012-09-11 | — | — | US | disclosed |